September 25th, 2024
GLP-1 medications have been a tipping point in exposing the role that PBM’s have over controlling prescription drug access and cost. Not all PBM’s are created equal and most drive what is easiest and most profitable for the PBM. It’s critical that employers play an active role in controlling their health plan strategy to support improved health outcomes and health plan investments. Tune into this episode of The Pulse as we uncover the role of the PBM in prescription drug access and costs and what employers need to do to redefine expectations and outcomes from PBMs.
Panelists will discuss:
September 25
11-12 Eastern
Professor at Johns Hopkins Carey Business School and Professor of Health Management at Johns Hopkins Bloomberg School of Public Health
Associate Professor at Stanford University School of Medicine and Program Director of Medical Weight Loss at the Clinical Resource Hub Weight Management Center at the Palo Alto Veteran’s Affairs
Assistant Vice President – Pharmacy at AECRx